Department of Obstetrics and Gynecology
Setsuko Chambers has not added Biography.
If you are Setsuko Chambers and would like to personalize this page please email our Author Liaison for assistance.
Procollagen-derived biomarkers in malignant ascites of ovarian cancer. Independent prognosticators for progression-free interval and survival.
Gynecologic oncology Oct, 2002 | Pubmed ID: 12468338
Vaginal intraepithelial neoplasia: treatment by carbon dioxide laser and risk factors for failure.
European journal of obstetrics, gynecology, and reproductive biology Jan, 2003 | Pubmed ID: 12475584
An unexpected effect of glucocorticoids on stimulation of c-fms proto-oncogene expression in choriocarcinoma cells that express little glucocorticoid receptor.
American journal of obstetrics and gynecology Apr, 2004 | Pubmed ID: 15118624
Endometrial glandular dysplasia: a newly defined precursor lesion of uterine papillary serous carcinoma. Part I: morphologic features.
International journal of surgical pathology Jul, 2004 | Pubmed ID: 15306933
Endometrial glandular dysplasia: a putative precursor lesion of uterine papillary serous carcinoma. Part II: molecular features.
International journal of surgical pathology Oct, 2004 | Pubmed ID: 15494858
Paraneoplastic limbic encephalitis: ovarian cancer presenting as an amnesic syndrome.
Obstetrics and gynecology Nov, 2004 | Pubmed ID: 15516442
SGK1, a potential regulator of c-fms related breast cancer aggressiveness.
Clinical & experimental metastasis , 2004 | Pubmed ID: 15679045
Systematic lymphadenectomy in advanced epithelial ovarian cancer: two decades of uncertainty resolved.
Journal of the National Cancer Institute Apr, 2005 | Pubmed ID: 15840870
Glyceraldehyde-3-phosphate dehydrogenase binds to the AU-Rich 3' untranslated region of colony-stimulating factor-1 (CSF-1) messenger RNA in human ovarian cancer cells: possible role in CSF-1 posttranscriptional regulation and tumor phenotype.
Cancer research May, 2005 | Pubmed ID: 15867372
Correlation of tumor phenotype with c-fms proto-oncogene expression in an in vivo intraperitoneal model for experimental human breast cancer metastasis.
Clinical & experimental metastasis , 2005 | Pubmed ID: 16132573
Precursors of endometrial clear cell carcinoma.
The American journal of surgical pathology Dec, 2006 | Pubmed ID: 17122507
Occurrence of endometrial glandular dysplasia precedes uterine papillary serous carcinoma.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists Jan, 2007 | Pubmed ID: 17197896
Histopathology of endometrial hyperplasia and endometrial carcinoma. An update by Dr LC Horn et al in Annals of Diagnostic Pathology 2007;11:297-311.
Annals of diagnostic pathology Jun, 2008 | Pubmed ID: 18486902
The multifunctional protein glyceraldehyde-3-phosphate dehydrogenase is both regulated and controls colony-stimulating factor-1 messenger RNA stability in ovarian cancer.
Molecular cancer research : MCR Aug, 2008 | Pubmed ID: 18708368
Enhanced ovarian cancer tumorigenesis and metastasis by the macrophage colony-stimulating factor.
Neoplasia (New York, N.Y.) Feb, 2009 | Pubmed ID: 19177198
HuR expression in the nucleus correlates with high histological grade and poor disease-free survival in ovarian cancer.
The Australian & New Zealand journal of obstetrics & gynaecology Feb, 2009 | Pubmed ID: 19281587
Biomarker targets and novel therapeutics.
Cancer treatment and research , 2009 | Pubmed ID: 19763432
Role of CSF-1 in progression of epithelial ovarian cancer.
Future oncology (London, England) Nov, 2009 | Pubmed ID: 19903070
Personal history of breast cancer as a significant risk factor for endometrial serous carcinoma in women aged 55 years old or younger.
International journal of cancer Feb, 2011 | Pubmed ID: 20473885
Ovarian cancer metastatic to the breast presenting as inflammatory breast cancer: a case report and literature review.
Journal of Cancer Jun, 2010 | Pubmed ID: 20842221
Posttranscriptional suppression of proto-oncogene c-fms expression by vigilin in breast cancer.
Molecular and cellular biology Jan, 2011 | Pubmed ID: 20974809
Overexpression of tumor vascular endothelial growth factor A may portend an increased likelihood of progression in a phase II trial of bevacizumab and erlotinib in resistant ovarian cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research Nov, 2010 | Pubmed ID: 21041183
Inhibition of the c-fms proto-oncogene autocrine loop and tumor phenotype in glucocorticoid stimulated human breast carcinoma cells.
Breast cancer research and treatment Sep, 2011 | Pubmed ID: 21063905
Pilot study of the prospective identification of changes in cognitive function during chemotherapy treatment for advanced ovarian cancer.
The journal of supportive oncology Nov-Dec, 2010 | Pubmed ID: 21265392
Neoadjuvant and adjuvant chemotherapy of cervical cancer: mature results of the phase 2 PBM-PFU protocol.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society Apr, 2011 | Pubmed ID: 21436702
Tubal origin of 'ovarian' low-grade serous carcinoma.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc Nov, 2011 | Pubmed ID: 21701538
Randomized, double-blind, placebo-controlled phase II study of AMG 386 combined with weekly paclitaxel in patients with recurrent ovarian cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Feb, 2012 | Pubmed ID: 22184370
Phase I trial of intraperitoneal pemetrexed, cisplatin, and paclitaxel in optimally debulked ovarian cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research May, 2012 | Pubmed ID: 22421191
Investigation of bendamustine HCL in a phase 2 study in women with resistant ovarian cancer.
Investigational new drugs Feb, 2013 | Pubmed ID: 22580577
The significance of p53 isoform expression in serous ovarian cancer.
Future oncology (London, England) Jun, 2012 | Pubmed ID: 22764765
Regulation of colony stimulating factor-1 expression and ovarian cancer cell behavior in vitro by miR-128 and miR-152.
Molecular cancer Aug, 2012 | Pubmed ID: 22909061
An unusual BRCA mutation distribution in a high risk cancer genetics clinic.
Familial cancer Mar, 2013 | Pubmed ID: 23179792
Nucleolin mediates microRNA-directed CSF-1 mRNA deadenylation but increases translation of CSF-1 mRNA.
Molecular & cellular proteomics : MCP Jun, 2013 | Pubmed ID: 23471483
Lynch syndrome related endometrial cancer: clinical significance beyond the endometrium.
Journal of hematology & oncology Mar, 2013 | Pubmed ID: 23531335
Secretory cell expansion with aging: risk for pelvic serous carcinogenesis.
Gynecologic oncology Dec, 2013 | Pubmed ID: 24060413
Tubal origin of ovarian endometriosis.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc Aug, 2014 | Pubmed ID: 24390223
Biomarkers and endosalpingiosis in the ovarian and tubal microenvironment of women at high-risk for pelvic serous carcinoma.
American journal of cancer research , 2014 | Pubmed ID: 24482739
Autocrine inhibition of the c-fms proto-oncogene reduces breast cancer bone metastasis assessed with in vivo dual-modality imaging.
Experimental biology and medicine (Maywood, N.J.) Apr, 2014 | Pubmed ID: 24599884
Simultaneous multiplane imaging of human ovarian cancer by volume holographic imaging.
Journal of biomedical optics Mar, 2014 | Pubmed ID: 24676382
Randomised phase II study of docetaxel plus vandetanib versus docetaxel followed by vandetanib in patients with persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma: SWOG S0904.
European journal of cancer (Oxford, England : 1990) Jun, 2014 | Pubmed ID: 24709487
Flutamide and biomarkers in women at high risk for ovarian cancer: preclinical and clinical evidence.
Cancer prevention research (Philadelphia, Pa.) Sep, 2014 | Pubmed ID: 24950779
Tubal origin of ovarian low-grade serous carcinoma.
American journal of clinical and experimental obstetrics and gynecology Dec, 2013 | Pubmed ID: 25346935
Confocal microlaparoscope for imaging the fallopian tube.
Journal of biomedical optics Nov, 2014 | Pubmed ID: 25411899
Evaluation of a hypoxia regulated gene panel in ovarian cancer.
Cancer microenvironment : official journal of the International Cancer Microenvironment Society Apr, 2015 | Pubmed ID: 25998313
Cognitive function during and six months following chemotherapy for front-line treatment of ovarian, primary peritoneal or fallopian tube cancer: An NRG oncology/gynecologic oncology group study.
Gynecologic oncology Dec, 2015 | Pubmed ID: 26456812
Pilot Clinical Evaluation of a Confocal Microlaparoscope for Ovarian Cancer Detection.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society Feb, 2016 | Pubmed ID: 26745695
Mechanism of progestin resistance in endometrial precancer/cancer through Nrf2-AKR1C1 pathway.
Oncotarget Mar, 2016 | Pubmed ID: 26824415
Assessment of the Role of Intraoperative Frozen Section in Guiding Surgical Staging for Endometrial Cancer.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society Jun, 2016 | Pubmed ID: 27051054
Multispectral fluorescence imaging of human ovarian and fallopian tube tissue for early-stage cancer detection.
Journal of biomedical optics May, 2016 | Pubmed ID: 27220626
Noninvasive detection of enzyme activity in tumor models of human ovarian cancer using catalyCEST MRI.
Magnetic resonance in medicine May, 2017 | Pubmed ID: 27221386
Cytologic studies of the fallopian tube in patients undergoing salpingo-oophorectomy.
Cancer cell international , 2016 | Pubmed ID: 27733814
Clinical Translation of Tumor Acidosis Measurements with AcidoCEST MRI.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging Aug, 2017 | Pubmed ID: 27896628
Expression of the cytoplasmic nucleolin for post-transcriptional regulation of macrophage colony-stimulating factor mRNA in ovarian and breast cancer cells.
Biochimica et biophysica acta Mar, 2017 | Pubmed ID: 28131007
1Department of Pathology, University of Arizona College of Medicine,
2Department of Obstetrics and Gynecology, Henan Provincial People's Hospital,
3Department of Obstetrics and Gynecology, University of Arizona College of Medicine,
4, University of Arizona Cancer Center,
5Department of Pathology, University of Texas Southwestern Medical Center,
6Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved